Yourgene QST*R Base test screens for trisomies 13, 18, 21 and sex chromosome aneuploidies using 22 markers. CE IVD certified.
The Prenatal Aneuploidy Testing, Yourgene QST*R Base test is a comprehensive prenatal aneuploidy screening solution utilizing 22 chromosome-specific markers. This test simultaneously screens for the most common viable autosomal trisomies (13, 18, and 21) and sex chromosome aneuploidies (X and Y) using Quantitative Fluorescent PCR (QF-PCR) technology.
Key Features
- Detects 22 markers across chromosomes 13, 18, 21, X, and Y
- Screens for autosomal trisomies and sex chromosome aneuploidies
- CE IVD certified for diagnostic use
- Rapid turnaround time for prenatal diagnosis
- High sensitivity and specificity
- Suitable for amniocentesis and chorionic villus sampling (CVS)
Clinical Applications
- Prenatal diagnosis of Down syndrome (trisomy 21)
- Edwards syndrome (trisomy 18) detection
- Patau syndrome (trisomy 13) detection
- Sex chromosome aneuploidy screening (Turner, Klinefelter syndromes)
About Yourgene Health
Yourgene Health (formerly Premaitha Health) is a leading molecular diagnostics company specializing in reproductive health, precision medicine, and genetic testing solutions. The Elucigene range of products represents high-quality CE IVD certified diagnostic tests designed for clinical laboratory use.